| Aaron William Montani, DO | |
|
3401 N Broad St, Philadelphia, PA 19140-5103 | |
| (215) 707-2000 | |
| Not Available |
| Full Name | Aaron William Montani |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 3401 N Broad St, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003476524 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | OS022703 (Pennsylvania) | Primary |
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
The Organization of Teratology Information Specialists (OTIS), a non-profit organization based at the University of California, San Diego with affiliates across North America, urges pregnant women to receive the influenza vaccine as soon as possible. The recommendation comes shortly after the American College of Obstetricians and Gynecologists Committee on Obstetric Practice issued new guidelines regarding the influenza vaccine during pregnancy.
Menopause can be a real rollercoaster—and that can impact women's sex lives. It can cause women's libidos to climb, suddenly drop, and then climb again due to the combination of estrogen and women's own levels of testosterone powering this wild cycle.
Researchers in the United States have shown that water-soluble derivatives of vitamin E (α-tocopherol) exhibit potent antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The University of Nebraska-Lincoln has earned an $11.3 million grant from the National Institutes of Health to establish a research center focused on investigating cellular level miscommunications that contribute to complex diseases such as cancer, diabetes and chronic liver disease.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaron William Montani, DO 1324 Locust St Apt 405, Philadelphia, PA 19107-5644 Ph: (717) 823-2285 | Aaron William Montani, DO 3401 N Broad St, Philadelphia, PA 19140-5103 Ph: (215) 707-2000 |
News Archive
The Organization of Teratology Information Specialists (OTIS), a non-profit organization based at the University of California, San Diego with affiliates across North America, urges pregnant women to receive the influenza vaccine as soon as possible. The recommendation comes shortly after the American College of Obstetricians and Gynecologists Committee on Obstetric Practice issued new guidelines regarding the influenza vaccine during pregnancy.
Menopause can be a real rollercoaster—and that can impact women's sex lives. It can cause women's libidos to climb, suddenly drop, and then climb again due to the combination of estrogen and women's own levels of testosterone powering this wild cycle.
Researchers in the United States have shown that water-soluble derivatives of vitamin E (α-tocopherol) exhibit potent antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
The University of Nebraska-Lincoln has earned an $11.3 million grant from the National Institutes of Health to establish a research center focused on investigating cellular level miscommunications that contribute to complex diseases such as cancer, diabetes and chronic liver disease.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
› Verified 6 days ago
Priscilla Nelson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, 6 Dulles, Philadelphia, PA 19104 Phone: 215-349-8310 | |
Nicole Lynn Renaldi, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 111 S 11th St, Suite 8490, Philadelphia, PA 19107 Phone: 215-955-6161 Fax: 215-923-5507 | |
Monique Lorraine Roberts, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-662-4000 | |
Sarah Kumar, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, Philadelphia, PA 19104 Phone: 215-349-8310 Fax: 215-893-7270 | |
Akshat Gargya, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Department Of Anesthesiology Temple University Hospital, Philadelphia, PA 19140 Phone: 847-660-4085 | |
Dr. Shreyas Ranganna, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3400 Spruce Street, Philadelphia, PA 19104 Phone: 732-861-2548 |